Literature DB >> 17275601

Predicting the outcome of surgery for the proximal interphalangeal joint in Dupuytren's disease.

Alok Misra1, Abhilash Jain, Reza Ghazanfar, Terrencia Johnston, Jagdeep Nanchahal.   

Abstract

PURPOSE: We prospectively studied the outcome of limited Dupuytren's fasciectomy, in combination with joint release if necessary, for disease involving 49 proximal interphalangeal joints (PIPJs) to identify factors that predispose to recurrent PIPJ contracture.
METHODS: Thirty-seven patients were treated over a 4-year period. The flexion contracture of the PIPJ was measured before surgery, immediately after surgery, and at more than 1 year after surgery.
RESULTS: A mean preoperative flexion contracture of 67 degrees +/- 22 degrees was corrected to 6 degrees +/- 10 degrees at the time of surgery and 25 degrees +/- 25 degrees at the follow-up evaluation. There was a positive correlation between the severity of the preoperative flexion contracture and recurrent deformity, with a preoperative contracture greater than 60 degrees leading to significantly worse outcome. Incomplete correction of PIPJ flexion contracture during surgery and poor postoperative compliance with therapy were also associated with worse recurrent joint contractures. The digit involved and the necessity for joint release did not significantly affect outcome.
CONCLUSIONS: In the absence of recurrent Dupuytren's disease, severe preoperative deformity, incomplete correction at surgery, and noncompliance with therapy predispose patients to worse PIPJ contracture. TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic II.

Entities:  

Mesh:

Year:  2007        PMID: 17275601     DOI: 10.1016/j.jhsa.2006.11.015

Source DB:  PubMed          Journal:  J Hand Surg Am        ISSN: 0363-5023            Impact factor:   2.230


  10 in total

1.  Experiences with pins and rubber band traction in the treatment of proximal interphalangeal joint contracture.

Authors:  Kevin C Cahill; Christoph Theopold; Michael O'Shaughnessy
Journal:  Plast Surg (Oakv)       Date:  2016       Impact factor: 0.947

2.  Surgical complications associated with fasciectomy for dupuytren's disease: a 20-year review of the English literature.

Authors:  Keith Denkler
Journal:  Eplasty       Date:  2010-01-27

3.  A systematic review of outcomes of fasciotomy, aponeurotomy, and collagenase treatments for Dupuytren's contracture.

Authors:  Neal C Chen; Ramesh C Srinivasan; Melissa J Shauver; Kevin C Chung
Journal:  Hand (N Y)       Date:  2011-03-01

Review 4.  Dupuytren's disease: current state of the art.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2014-03

Review 5.  Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.

Authors:  Catherine Ball; Anna L Pratt; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2013-04-10       Impact factor: 2.362

6.  Clinical Results of Percutaneous Needle Fasciotomy for Dupuytren's Disease in Japanese Patients.

Authors:  Yoshihiro Abe; Susumu Tokunaga
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-06-05

Review 7.  What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.

Authors:  Anna L Pratt; Catherine Ball
Journal:  BMC Musculoskelet Disord       Date:  2016-01-13       Impact factor: 2.362

8.  Phalangeal Fracture During Attempted Dupuytrens Release Following Clostridial Collagenase Injection: Case Report.

Authors:  Laura W Lewallen; Marco Rizzo
Journal:  J Orthop Case Rep       Date:  2017 Jul-Aug

9.  The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.

Authors:  Lynn E Murphy; Karen M Murphy; Shauneen M Kilpatrick; Neville W Thompson
Journal:  Ulster Med J       Date:  2017-05-20

Review 10.  Clinical effectiveness of post-operative splinting after surgical release of Dupuytren's contracture: a systematic review.

Authors:  Debbie Larson; Christina Jerosch-Herold
Journal:  BMC Musculoskelet Disord       Date:  2008-07-21       Impact factor: 2.362

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.